Cuál es el precio por Pangaea Oncology, S.A. (PANG)

Precio por Pangaea Oncology, S.A. (PANG) es de$1.84

Cuál es la capitalización de mercado por Pangaea Oncology, S.A. (PANG)

Capitalización de mercado por Pangaea Oncology, S.A. (PANG) es $66.03M

Ganancias de Pangaea Oncology, S.A. (PANG)

Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.

Año	Ganancias	Cambiar
Not enough data for the provided dates.

Año

Ganancias

Cambiar

Not enough data for the provided dates.

Empresa	Ganancias	Diferencia de ganancias	País
Thermo Fisher Scientific Inc. TMO.US	$7.61B	-	US
Danaher Corporation DHR.US	$4.76B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-252.70M	-	US
Agilent Technologies, Inc. A.US	$1.58B	-	US

Empresa

Ganancias

Diferencia de ganancias

País